Free Trial
OTCMKTS:RYES

Rise Gold (RYES) Stock Price, News & Analysis

Rise Gold logo
$0.19 -0.03 (-13.23%)
As of 03:53 PM Eastern

About Rise Gold Stock (OTCMKTS:RYES)

Advanced

Key Stats

Today's Range
$0.19
$0.23
50-Day Range
$0.14
$0.29
52-Week Range
$0.04
$0.32
Volume
80,185 shs
Average Volume
54,297 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive RYES Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Rise Gold and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

RYES Stock News Headlines

Gold Prices Rise to Record, Again
Is *BSEM* Oversold??
BioStem Technologies Inc. (OTC: BSEM) is emerging as one of the most exciting MedTech stories of 2025. The company delivered record-breaking revenues in 2024 and Q1 2025, including $72.5 million in net revenue for Q1 — a 73% increase over the prior year — and six consecutive quarters of positive adjusted EBITDA. With cash reserves rising to $30.8 million and a growing patent portfolio of 58 issued and 68 pending patents, BSEM is scaling profitably while advancing its proprietary BioREtain® technology, which has shown clinically superior results for chronic, non-healing wounds. National recognition is adding to the momentum, with CEO Jason Matuszewski named EY Entrepreneur of the Year 2025 Florida Award winner, validating the leadership driving this high-growth MedTech powerhouse.tc pixel
See More Headlines

RYES Stock Analysis - Frequently Asked Questions

Rise Gold's stock was trading at $0.0833 at the beginning of the year. Since then, RYES stock has increased by 124.5% and is now trading at $0.1870.

Shares of RYES stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Rise Gold investors own include Eldorado Gold (EGO), NU (NU), Alcentra Capital (ABDC), Amarillo Gold (AGC), DSP Group (DSPG), Energy Transfer Equity (ETE) and (JPEP) (JPEP).

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Industry
Gold
Sub-Industry
Non-Metallic And Industrial Metal Mining
Current Symbol
OTCMKTS:RYES
CIK
1424864
Fax
N/A
Employees
1
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
N/A
Price / Book
N/A

Miscellaneous

Outstanding Shares
N/A
Free Float
N/A
Market Cap
N/A
Optionable
Not Optionable
Beta
N/A
The 10 Best AI Stocks to Own in 2025 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

This page (OTCMKTS:RYES) was last updated on 10/16/2025 by MarketBeat.com Staff
From Our Partners